This opportunity is no longer accepting applications.
grant PAR-23-081

Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

This grant opportunity seeks applications to develop and conduct clinical trials for treatments addressing cognitive and neuropsychiatric changes related to aging, Alzheimer's disease, and related dementias. It covers trials for both drug and non-drug interventions at various disease stages, from pre-symptomatic to severe. The grant also aims to encourage research on improving trial design and…

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-rela…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: December 23, 2022
Open for Submission: December 23, 2022
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.